Adverse events and oncotargeted kinase inhibitors / (Record no. 29788)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01467cam a22003257a 4500 |
001 - CONTROL NUMBER | |
control field | 29788 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | MED |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250512124731.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 170807t20172017xx b 001 0 eng d |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER | |
LC control number | 2017302047 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9780128094006 (hbk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 0128094001 (hbk.) |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (OCoLC)ocn959880103 |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | YDX |
Language of cataloging | eng |
Transcribing agency | YDX |
Modifying agency | BDX |
-- | OCLCQ |
-- | BTCTA |
-- | WSU |
-- | OCLCF |
-- | DLC |
042 ## - AUTHENTICATION CODE | |
Authentication code | lccopycat |
050 00 - LIBRARY OF CONGRESS CALL NUMBER | |
Classification number | RC271.P76 |
Item number | T75 2017 |
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 615.7/98 |
Edition number | 23 |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Tridente, G., |
Relator term | author. |
245 10 - TITLE STATEMENT | |
Title | Adverse events and oncotargeted kinase inhibitors / |
Statement of responsibility, etc. | Giuseppe Tridente. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Place of publication, distribution, etc. | London : |
Name of publisher, distributor, etc. | Academic Press, |
Date of publication, distribution, etc. | ©2017. |
300 ## - PHYSICAL DESCRIPTION | |
Extent | xix, 715 p. ; |
Dimensions | 28 cm |
504 ## - BIBLIOGRAPHY, ETC. NOTE | |
Bibliography, etc. note | Includes bibliographical references and index. |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Introduction -- Kinases -- Kinase inhibitors -- Adverse events -- Imantinib -- Gefitinib -- Erlotinib -- Sorafenib -- Sunitinib -- Dasatinib -- Lapatinib -- Nilotinib -- Pazopanib -- Vandetanib -- Vemurafenib -- Crizotinib -- Ruxolitinib -- Axitinib -- Bosutinib -- Regorafenib -- Cabozantinib -- Ponatinib -- Dabrafenib -- Trametinib -- Afatinib -- Idelaisib -- Ibrutinib -- Overview -- Conclusion and perspectives. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Protein-tyrosine kinase |
General subdivision | Inhibitors. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Protein-tyrosine kinase $x Inhibitors. |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Protein-tyrosine kinase |
General subdivision | Inhibitors. |
Source of heading or term | fast |
Authority record control number or standard number | (OCoLC)fst01079707 |
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) | |
a | 7 |
b | cbc |
c | copycat |
d | 2 |
e | ncip |
f | 20 |
g | y-gencatlg |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Source of classification or shelving scheme | Library of Congress Classification |
Koha item type | كتاب |
Suppress in OPAC | No |
Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Inventory number | Total checkouts | Full call number | Date last seen | Price effective from | Koha item type | Public note |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Library of Congress Classification | الطب | الطب | 05/12/2025 | 0006 1706 | RC 271 | 05/12/2025 | 05/12/2025 | كتاب | مكتبة كلية طب الموصل |